Estamos realizando la búsqueda. Por favor, espere...


Drug weaponry to fight against SARS-CoV-2

Abstract: The current outbreak of SARS-CoV-2 virus has caused a large increase in mortality and morbidity associated with respiratory diseases. Huge efforts are currently ongoing to develop a vaccine against this virus. However, alternative approaches could be considered in the fight against this disease. Among other strategies, structural-based drug design could be an effective approach to generate specific molecules against SARS-CoV-2, thus reducing viral burden in infected patients. Here, in addition to this structural approach, we also revise several therapeutic strategies to fight against this viral threat. Furthermore, we report ACE-2 genetic polymorphic variants affecting residues involved in close contacts with SARS-CoV-2 that might be associated to different infection risks. These analyses could provide valuable information to predict the course of the disease.

 Autoría: Cabezón E., Arechaga I.,

 Fuente: Frontiers in molecular biosciences 2020; 7: 204

Editorial: Frontiers Media

 Año de publicación: 2020

Nº de páginas: 11

Tipo de publicación: Artículo de Revista

 DOI: 10.3389/fmolb.2020.00204

ISSN: 2296-889X

Url de la publicación: https//DOI: 10.3389/fmolb.2020.00204